5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia

Letter/Communication

Vicki L Ellingrod, Paul J Perry, Brian C Lund, Kristy Bever-Stille, Frank Fleming, Timothy L Holman and Del Miller

Journal of clinical psychopharmacology, Vol.22(6), pp.622-624

12/2002

DOI: 10.1097/00004714-200212000-00014

PMID: 12454564

View Online

Schizophrenia - metabolism

Olanzapine

Antipsychotic Agents - blood

Humans

Middle Aged

Pirenzepine - therapeutic use

Pirenzepine - analogs & derivatives

Treatment Outcome

Receptors, Serotonin - genetics

Receptor, Serotonin, 5-HT2A

Benzodiazepines

Receptors, Serotonin - metabolism

Receptor, Serotonin, 5-HT2C

Dose-Response Relationship, Drug

Pirenzepine - blood

Psychiatric Status Rating Scales

Antipsychotic Agents - therapeutic use

Adolescent

Adult

Polymorphism, Genetic - genetics

Aged

Schizophrenia - drug therapy

Title: Subtitle: 5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia
Creators: Vicki L Ellingrod
Paul J Perry
Brian C Lund
Kristy Bever-Stille
Frank Fleming
Timothy L Holman
Del Miller
Resource Type: Letter/Communication
Publication Details: Journal of clinical psychopharmacology, Vol.22(6), pp.622-624
Publisher: United States
DOI: 10.1097/00004714-200212000-00014
PMID: 12454564
ISSN: 0271-0749
eISSN: 1533-712X
Language: English
Date published: 12/2002
Academic Unit: Pharmacy; Psychiatry; Epidemiology
Record Identifier: 9984004089602771

42 Record Views